Anika Therapeutics (ANIK) Construction in Progress (2011 - 2016)

Anika Therapeutics (ANIK) has 6 years of Construction in Progress data on file, last reported at $22.7 million in Q4 2016.

• Construction in Progress for Q4 2016 came in at $22.7 million, up 101.3% year-over-year; the trailing twelve-month figure through Dec 2016 was $22.7 million (up 101.3% YoY), and the FY2016 annual result was $22.7 million, up 101.3% from the prior year.
• Construction in Progress rose to $22.7 million in Q4 2016 per ANIK's latest filing, from $11.3 million in the prior quarter.
• Over five years, Construction in Progress peaked at $22.7 million in Q4 2016 and troughed at $42270.0 in Q4 2012.
• A 5-year average of $6.9 million and a median of $559000.0 in 2014 frame the typical range for Construction in Progress.
• The sharpest annual moves came in 2012 and 2015: Construction in Progress plunged 99.84% in 2012, then jumped 1916.82% in 2015.
• A 5-year view of Construction in Progress shows it stood at $42270.0 in 2012, then soared by 272.11% to $157292.0 in 2013, then surged by 255.39% to $559000.0 in 2014, then jumped by 1916.82% to $11.3 million in 2015, then soared by 101.3% to $22.7 million in 2016.
• Business Quant data shows ANIK's Construction in Progress at $22.7 million in Q4 2016, $11.3 million in Q4 2015, and $559000.0 in Q4 2014.